Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.

MLA

Otto, Raik, et al. “Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.” Cancers, vol. 15, no. 3, Feb. 2023, p. 936. EBSCOhost, https://doi.org/10.3390/cancers15030936.

APA

Otto, R., Detjen, K. M., Riemer, P., Fattohi, M., Grötzinger, C., Rindi, G., Wiedenmann, B., Sers, C., & Leser, U. (2023). Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics. Cancers, 15(3), 936. https://doi.org/10.3390/cancers15030936

Chicago

Otto, Raik, Katharina M. Detjen, Pamela Riemer, Melanie Fattohi, Carsten Grötzinger, Guido Rindi, Bertram Wiedenmann, Christine Sers, and Ulf Leser. 2023. “Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.” Cancers 15 (3): 936. doi:10.3390/cancers15030936.